Tarsus Pharmaceuticals, Inc. (TARS) SEC Filings — 2025
10 SEC filings for Tarsus Pharmaceuticals, Inc. (TARS) in 2025.
Filings
- Tarsus Narrows Losses as XDEMVY Sales Soar 163% — 10-Q · Nov 4, 2025
- Tarsus's XDEMVY Drives Revenue Surge Amid Widening Losses — 10-Q · Aug 6, 2025
- Tarsus Pharma Files 8-K on Shareholder Vote Matters — 8-K · Jun 18, 2025
- Tarsus Pharmaceuticals Q1 2025 10-Q Filing — 10-Q · May 1, 2025
- Tarsus Pharma Files Proxy Statement for 2025 Shareholder Meeting — DEF 14A · Apr 28, 2025
- DuPont Acquires Tarsus Pharmaceuticals for $1.1 Billion — 8-K · Mar 18, 2025
- Tarsus Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 13, 2025
- Tarsus Pharmaceuticals, Inc. 10-K Filing — 10-K · Feb 25, 2025
- Tarsus Pharmaceuticals Relocates Principal Offices — 8-K · Jan 17, 2025
- Tarsus Pharmaceuticals Files Current Report — 8-K · Jan 13, 2025